Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?
The FASEB Journal · 15.02.2024 · 38 (3)
DOI: 10.1096/fj.202302447r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 06.02.2024. Verfasst von Patrycja Jakubek und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland. Hauptthemen laut MEDLINE: Metabolic Diseases, Fatty Liver. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la ricerca sul cancro ETS (AIRC), Ministero dell'Università e della Ricerca (MUR), EC | HORIZON EUROPE Framework Programme (Horizon Europe).
Abstract (Originalsprache)
Despite decades of research, the pathogenesis of metabolic dysfunction‐associated steatotic liver disease (MASLD) is still not completely understood. Based on the evidence from preclinical models, one of the factors proposed as a main driver of disease development is oxidative stress. This study aimed to search for the resemblance between the profiles of oxidative stress and antioxidant defense in the animal model of MASLD and the group of MASLD patients. C57BL/6J mice were fed with the Western diet for up to 24 weeks and served as the animal model of MASLD. The antioxidant profile of mice hepatic tissue was determined by liquid chromatography‐MS3 spectrometry (LC–MS/MS). The human cohort consisted of 20 patients, who underwent bariatric surgery, and 6 controls. Based on histological analysis, 4 bariatric patients did not have liver steatosis and as such were also classified as controls. Total antioxidant activity was measured in sera and liver biopsy samples. The hepatic levels of antioxidant enzymes and oxidative damage were determined by Western Blot. The levels of antioxidant enzymes were significantly altered in the hepatic tissue of mice with MASLD. In contrast, there were no significant changes in the antioxidant profile of hepatic tissue of MASLD patients, except for the decreased level of carbonylated proteins. Decreased protein carbonylation together with significant correlations between the thioredoxin system and parameters describing metabolic health suggest alterations in the thiol‐redox signaling. Altogether, these data show that even though the phenotype of mice closely resembles human MASLD, the animal‐to‐human translation of cellular and molecular processes such as oxidative stress may be more challenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Mitochondrial Biology and Metabolism, Nencki Institute of Experimental Biology of Polish Academy of Sciences, Warsaw, Poland.
- Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
- Department of Pathology, The Children's Memorial Health Institute, Warsaw, Poland.
- Laboratory of Metabolic Liver Diseases, Department of General, Transplant and Liver Surgery, Centre for Preclinical Research, Medical University of Warsaw, Warsaw, Poland.
- Department of Medical Sciences, Section of Experimental Medicine, Laboratory for Technologies of Advanced Therapies, University of Ferrara, Ferrara, Italy.
- Liver and Internal Medicine Unit, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
ORCID-Profile: Patrycja Jakubek, Piotr Kalinowski, Agnieszka Karkucinska-Wieckowska, Aakruti Kaikini, Inês C M Simões, Yaiza Potes, Beata Kruk, Wieslawa Grajkowska, Paolo Pinton, Piotr Milkiewicz, Michał Grąt, Maciej Pronicki, Magdalena Lebiedzinska-Arciszewska, Marcin Krawczyk, Mariusz R Wieckowski
Förderung
- Fondazione AIRC per la ricerca sul cancro ETS (AIRC)
- Ministero dell'Università e della Ricerca (MUR)
- EC | HORIZON EUROPE Framework Programme (Horizon Europe)
- Narodowe Centrum Nauki (NCN)
Zitieren
APA
Jakubek, P., Kalinowski, P., Karkucinska-Wieckowska, A., Kaikini, A., Simões, I. C. M., Potes, Y., Kruk, B., Grajkowska, W., Pinton, P., Milkiewicz, P., Grąt, M., Pronicki, M., Lebiedzinska-Arciszewska, M., Krawczyk, M., & Wieckowski, M. R. (2024). Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?. The FASEB Journal, 38(3). https://doi.org/10.1096/fj.202302447r
Vancouver
Jakubek P, Kalinowski P, Karkucinska-Wieckowska A, Kaikini A, Simões ICM, Potes Y, et al. Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?. The FASEB Journal. 2024;38(3). doi:10.1096/fj.202302447r
BibTeX
@article{Jakubek2024,
author = {Jakubek, Patrycja and Kalinowski, Piotr and Karkucinska-Wieckowska, Agnieszka and Kaikini, Aakruti and Simões, Inês C M and Potes, Yaiza and Kruk, Beata and Grajkowska, Wieslawa and Pinton, Paolo and Milkiewicz, Piotr and Grąt, Michał and Pronicki, Maciej and Lebiedzinska-Arciszewska, Magdalena and Krawczyk, Marcin and Wieckowski, Mariusz R},
title = {Oxidative stress in metabolic dysfunction‐associated steatotic liver disease ( MASLD ): How does the animal model resemble human disease?},
journal = {The FASEB Journal},
year = {2024},
volume = {38},
number = {3},
doi = {10.1096/fj.202302447r}
}
EUVIMED